Kunihiko Kobayashi

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 10

Top Topics

Interstitial Lung Disease

Direct Oral Anticoagulants

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Cancer research

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Atsuto Mouri, Satoshi Watanabe, Takaaki Tokito, Yoshiaki Nagai, Yu Saida, Hisao Imai, Ou Yamaguchi, Kunihiko Kobayashi, Kyoichi Kaira, Hiroshi Kagamu
Clinical Outcome of Nivolumab Plus Ipilimumab in Patients with Locally Advanced Non-Small-Cell Lung Cancer with Relapse after Concurrent Chemoradiotherapy followed by Durvalumab. Cancers 16 (7) (2024)
Pasi A Janne, David Planchard, Kunihiko Kobayashi, James Chih-Hsin Yang
Reply to Y. Yu et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Keita Kawakado, Yukari Tsubata, Takamasa Hotta, Masahiro Yamasaki, Nobuhisa Ishikawa, Kazunori Fujitaka, Tetsuya Kubota, Kunihiko Kobayashi, Takeshi Isobe
Risk Factors for Bleeding Events in Japanese Patients with Advanced Lung Cancer: Data from the Rising-VTE/NEJ037 Study. Cancers 16 (2) (2024)
Pasi A Janne, David Planchard, Kunihiko Kobayashi, James Chih-Hsin Yang
Reply to Y. Yu et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Keita Kawakado, Yukari Tsubata, Takamasa Hotta, Masahiro Yamasaki, Nobuhisa Ishikawa, Kazunori Fujitaka, Tetsuya Kubota, Kunihiko Kobayashi, Takeshi Isobe
Risk Factors for Bleeding Events in Japanese Patients with Advanced Lung Cancer: Data from the Rising-VTE/NEJ037 Study. Cancers 16 (2) (2024)
Atsuto Mouri, Satoshi Watanabe, Takaaki Tokito, Yoshiaki Nagai, Yu Saida, Hisao Imai, Ou Yamaguchi, Kunihiko Kobayashi, Kyoichi Kaira, Hiroshi Kagamu
Clinical Outcome of Nivolumab Plus Ipilimumab in Patients with Locally Advanced Non-Small-Cell Lung Cancer with Relapse after Concurrent Chemoradiotherapy followed by Durvalumab. Cancers 16 (7) (2024)
Pasi A Janne, David Planchard, Kunihiko Kobayashi, James Chih-Hsin Yang
Reply to Y. Yu et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Akitoshi Yanagihara, Satoshi Yamasaki, Kosuke Hashimoto, Ryo Taguchi, Tetsuya Umesaki, Hisao Imai, Kyoichi Kaira, Hiroyuki Nitanda, Hirozo Sakaguchi, Hironori Ishida, Kunihiko Kobayashi, Katsuhisa Horimoto, Hiroshi Kagamu
A Th1-like CD4 + T-cell Cluster That Predicts Disease-free Survival in Early-stage Lung Cancer. Cancer research communications 3 (7) (2023)
Pasi A Janne, David Planchard, Kunihiko Kobayashi, Ying Cheng, Chee Khoon Lee, Natalia Valdivieso, Konstantin Laktionov, Tsung-Ying Yang, Yan Yu, Terufumi Kato, Liyan Jiang, Busayamas Chewaskulyong, Sarayut L Geater, Jean-Marc Maurel, Carlos Rojas, Toshiaki Takahashi, Libor Havel, Frances A Shepherd, Kentaro Tanaka, Dana Ghiorghiu, Neha P Amin, Elena Armenteros-Monterroso, Xiangning Huang, Ammar Ahmed Chaudhry, James Chih-Hsin Yang
CNS Efficacy of Osimertinib With or Without Chemotherapy in Epidermal Growth Factor Receptor-Mutated Advanced Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Hiroshi Kagamu, Satoshi Yamasaki, Shigehisa Kitano, Ou Yamaguchi, Atsuto Mouri, Ayako Shiono, Fuyumi Nishihara, Yu Miura, Kosuke Hashimoto, Hisao Imai, Kyoichi Kaira, Kunihiko Kobayashi, Yae Kanai, Tatsuhiro Shibata, Katsuhisa Horimoto
Single-cell analysis reveals a CD4+ T cell cluster that correlates with PD-1 blockade efficacy. Cancer research (2022)